Prichard Heather's Insider Trades & SAST Disclosures

Prichard Heather's most recent trade in Humacyte Inc was a trade of 283,101 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 283,101 283,101 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 525 2,625 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share. 30 May 2024 78,779 81,404 - 2.6 201,674 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.36 per share. 30 May 2024 78,779 2,625 - 8.4 658,592 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 May 2024 78,779 0 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.71 per share. 30 May 2024 61,941 2,625 - 7.7 477,565 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.32 per share. 30 May 2024 48,166 2,625 - 8.3 400,741 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. 30 May 2024 48,166 50,791 - 3.1 147,870 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 May 2024 48,166 87,834 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Sale of securities on an exchange or to another person at price $ 9.41 per share. 30 May 2024 2,625 0 - 9.4 24,707 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2023 290,000 290,000 - - Stock Options (right to buy)
Humacyte Inc
Prichard Heather Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2023 525 2,100 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2023 64,990 0 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. 24 May 2023 64,990 74,179 - 1.2 77,338 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. 24 May 2023 13,789 22,978 - 1.2 16,409 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Sale of securities on an exchange or to another person at price $ 4.14 per share. 24 May 2023 13,789 9,189 - 4.1 57,086 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2023 13,789 64,990 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Sale of securities on an exchange or to another person at price $ 3.83 per share. 24 May 2023 9,613 64,566 - 3.8 36,818 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2022 6,564 0 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share. 12 Dec 2022 6,564 9,189 - 1.2 7,549 Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2022 136,000 136,000 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 157,558 157,558 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 78,779 78,779 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 78,779 78,779 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 6,564 6,564 - - Stock Options (right to buy)
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 2,625 2,625 - - Common Stock
Humacyte Inc
Heather Prichard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 1,575 1,575 - - Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades